Enteric fever, primarily caused by Salmonella Typhi and Salmonella Paratyphi, is a significant global health concern. This systemic infection, prevalent in regions with poor sanitation and water hygiene, requires adept clinical acumen for diagnosis and management. This article provides a comprehensive guide to the treatment of enteric fever for healthcare professionals.
Diagnosis is primarily based on clinical presentation, with fever, abdominal pain, and constipation being common symptoms. Blood culture remains the gold standard for diagnosis, although it has a sensitivity of only 40-60%. Molecular methods, such as PCR, are increasingly used for their higher sensitivity and specificity.
The cornerstone of enteric fever management is antimicrobial therapy. The choice of antibiotic depends on local susceptibility patterns. Fluoroquinolones were once the drug of choice but increasing resistance has led to the use of third-generation cephalosporins and azithromycin. Empirical therapy should be adjusted based on culture and sensitivity results.
Complications such as intestinal perforation and haemorrhage require immediate surgical intervention. Other complications like myocarditis, hepatitis, and neuropsychiatric manifestations necessitate supportive care alongside antimicrobial therapy.
Prevention strategies include improving sanitation, safe water supplies, and food safety. Vaccination also plays a crucial role in prevention, with two vaccines currently available: the oral live-attenuated Ty21a vaccine and the injectable Vi polysaccharide vaccine.
Enteric fever remains a global health challenge, particularly in low-resource settings. Successful management requires a multifaceted approach, encompassing accurate diagnosis, effective antimicrobial therapy, management of complications, and prevention strategies. As healthcare professionals, staying abreast of the latest developments in enteric fever management is crucial to providing optimal patient care.
1.
In Patients with Myeloma Who Postpone HSCT, Quadruplet Displays "Excellent Activity.".
2.
Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.
3.
Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer
4.
CAR T cells improve patients' quality of life: a study
5.
Preoperative Embolization Linked to Relapse-Free Survival in Meningioma
1.
The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025
2.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
3.
Bone Marrow Niche Remodeling in Hematologic Dysfunction
4.
Public Health Strategies for Expanding Early Support Systems in Blood Disorders
5.
Clinical Pharmacology of Megakaryocyte Maturation-Targeted Therapeutics
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
5.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation